ANNOUNCEMENT

Save $150 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Offer ends July 8..

Mayo Clinic-Cancer Genetics joint venture will put next-gen sequencing to work in diagnostics

Mayo Clinic-Cancer Genetics joint venture will put next-gen sequencing to work in diagnostics

May 22, 2013 4:58 pm by | 0 Comments

Now that next-generation DNA sequencing is fast enough, cheap enough and commercially available, the next challenging for innovators is finding ways to effectively apply it to everyday medicine outside of ... Read more

Fearless teen scientists are building PCR machines & finding better ways to detect cancer

Fearless teen scientists are building PCR machines & finding better ways to detect cancer

May 22, 2013 1:30 pm by | 0 Comments

At one point during my trip to FutureMed earlier this year, I found myself seated next to a young man — noticeably younger than many of the entrepreneurs and doctors-in-training ... Read more


Cambridge firm uses next-generation DNA sequencing to detect more mutations in carrier screening

Cambridge firm uses next-generation DNA sequencing to detect more mutations in carrier screening

May 16, 2013 3:39 pm by | 1 Comments

 When a company sets out to enter a market inhabited by heavyweights like LabCorp and Quest Diagnostics, it better have something good. Good Start Genetics has applied next-generation DNA sequencing ... Read more

Genetic testing, cancer and preventive surgery: Not just in breast cancer

Genetic testing, cancer and preventive surgery: Not just in breast cancer

May 14, 2013 4:30 pm by | 0 Comments

Angeline Jolie’s disclosure of her double mastectomy has drawn the mainstream media’s attention to genetic testing, a recent medical advancement with huge, albeit challenging, implications.Many experts predict that genetic testing ... Read more

Genomics research supplier rounds up $21.3 million from China-focused investors

Genomics research supplier rounds up $21.3 million from China-focused investors

March 22, 2013 10:16 am by | 0 Comments

In a demonstration of the booming field of genomic research, investors have pumped $21.3 million into a company that makes and manufactures genome-wide research tools and services.OriGene Technologies said its ... Read more

Online marketplace offers docs a little help navigating the new world of genetic testing

Online marketplace offers docs a little help navigating the new world of genetic testing

March 6, 2013 4:29 pm by | 1 Comments

Between three and five new genetic tests are introduced to the market each month, UnitedHealth Group told us in a report last May. While that may sound like a great ... Read more

Omics data company Syapse Inc. closes $3M series A led by ex-Facebook VP’s venture fund

Omics data company Syapse Inc. closes $3M series A led by ex-Facebook VP’s venture fund

January 22, 2013 9:00 am by | 0 Comments

Sequencing the genome is one thing. Making sense of the data that generates is another.That’s what Syapse Inc., self-proclaimed as “one of the largest repositories of human molecular profiles,” is ... Read more


Just in time for HIPAA update, researchers ID 50 men in genomic database

Just in time for HIPAA update, researchers ID 50 men in genomic database

January 18, 2013 8:27 pm by | 2 Comments

It’s the kind of thing that data privacy advocates fear most: that the massive amounts of de-identified genomic data collected through diagnostic tests and exchanged by scientists for research will ... Read more

Genetic analysis company NanoString will use $15.3M for first launch in molecular diagnostics

Genetic analysis company NanoString will use $15.3M for first launch in molecular diagnostics

December 3, 2012 11:54 am by | 0 Comments

A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics.NanoString Technologies Inc. said ... Read more

The $1,000 genome question has turned into, “How can we understand this data?”

The $1,000 genome question has turned into, “How can we understand this data?”

November 15, 2012 11:23 am by | 0 Comments

His most recent book is called The $1,000 Genome, but Kevin Davies says that the $100 genome isn’t out of reach in the move toward personalized medicine.The author and editor-in-chief ... Read more

Rosetta Genomics add chief medical officer, chief scientific officer

Rosetta Genomics add chief medical officer, chief scientific officer

October 11, 2012 9:48 am by | 0 Comments

Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that E. Robert Wassman, M.D. and Dganit Bar, Ph.D. will join the Company in the ... Read more

Women’s health test firm raising $7.3M to understand, identify genetic markers of birth defects

Women’s health test firm raising $7.3M to understand, identify genetic markers of birth defects

August 21, 2012 10:11 am by | 0 Comments

A genetic testing firm hoping to prevent the birth defect spina bifida by identifying genetic markers in pregnant women is raising money and conducting spina bifida research. ... Read more

RNAi drug delivery company secures $1.6M for endosomal escape technology

RNAi drug delivery company secures $1.6M for endosomal escape technology

July 24, 2012 1:23 pm by | 0 Comments

PhaseRx is developing a RNAi drug delivery system that uses synthetic polymers to help RNAi-based therapeutics escape endosomes and reach cell cytoplasm. ... Read more

Genomic analysis company gets $250K JumpStart investment

Genomic analysis company gets $250K JumpStart investment

June 5, 2012 12:55 pm by | 0 Comments

A bioinformatics company that’s developed software to analyze sequenced genomic data from cancer patients and their tumors has received a $250,000 investment from nonprofit business development group JumpStart.Cleveland-area GenomOncology had ... Read more

Software fast enough for custom-made cancer treatments?

Software fast enough for custom-made cancer treatments?

May 25, 2012 2:12 pm by | 0 Comments

A new approach to review the genetic makeup of cancer patients and their tumors could enable customized cancer treatments.It’s been too hard for scientists to analyze peoples’ genetic data. Figuring ... Read more